← Open Payments lookup

OLIVIA GIBSON-DELANEY: Open Payments

NPI 1881128924 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$427 in 24 payments from 11 companies in 2025. Trend: 2023 $587 · 2024 $571 · 2025 $427

Food & beverage: $427
CompanyPaymentsAmount
ABBVIE INC.5$88
Alkermes, Inc.4$70
Neurocrine BioSciences, Inc.3$58
Janssen Pharmaceuticals, Inc3$55
Otsuka America Pharmaceutical, Inc.2$35
Teva Pharmaceuticals USA, Inc.2$34
Lundbeck LLC1$18
Luye Pharma (USA) Ltd.1$18
E.R. Squibb & Sons, L.L.C.1$18
Bausch Health US, LLC1$16

Products named: VRAYLAR, ARISTADA, INGREZZA, INVEGA SUSTENNA, REXULTI, ERZOFRI EXTENDED-RELEASE, COBENFY, AUSTEDO XR.

Industry payments across NJ — which companies pay providers there.